Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharma company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results